Fagron
Fagron NV is a Belgian multinational healthcare company specializing in pharmaceutical compounding and customized medicine formulation. The company provides raw pharmaceutical essential ingredients, compounding vehicles, customized medication formulations, and sterile compounding services for hospitals and pharmacies. Main revenue drivers comprise global commercial sales of active pharmaceutical ingredients (APIs), compounding supplies, personalized medicine formulations, and outsourced sterile compounding fees. Fagron serves compounding pharmacies, hospital networks, prescribing physicians, research clinics, and patients across Europe, North America, and Latin America. The company holds a market-leading global position as a premier provider of customized pharmaceutical compounding solutions and API supplies. Headquartered in Nazareth, Belgium, Fagron NV is listed on Euronext Brussels and Euronext Amsterdam.
13 of the funds FundTelligence covers report a position in Fagron.
- Legal name
- Fagron SA
- Sector
- Health Care
- Country
- Belgium
- Funds holding it
- 13
Funds holding Fagron
- Aktie-Ansvar Europa — Aktie-Ansvar · 3.42 % (full portfolio disclosed, June 2026)
- Swedbank Robur Small Cap Global — Swedbank · 2.34 % (full portfolio disclosed, October 2026)
- Cliens Global Småbolag — Cliens · 1.87 % (full portfolio disclosed, June 2026)
- Indecap Guide Global Offensiv — Indecap · 1.49 % (full portfolio disclosed, June 2026)
- JPM Europe Dynamic Small Cap Fund — JPM · 0.97 % (full portfolio disclosed, December 2025)
- JPM Europe Small Cap Fund — JPM · 0.9 % (full portfolio disclosed, June 2026)
- JPM Europe Sustainable Small Cap Equity Fund — JPM · 0.61 % (full portfolio disclosed, June 2026)
- Swedbank Robur Healthcare — Swedbank · 0.25 % (full portfolio disclosed, October 2026)
Showing the 8 largest of 13 funds holding it.